A study of conflict-of-interest policies by researchers at Wake Forest and Duke Universities, published today in The New England Journal of Medicine, has concluded that investigators involved in clinical trials should do more to provide trial participants with meaningful disclosures of any of their financial conflicts, a conclusion that endorses guidelines issued last spring by the National Academies’ Institute of Medicine.
|
Previous Illinois Governor Drops Fight With 2 Trustees and Appoints 2 More |
Next Agreement Allows Work to Proceed on New Teaching Hospital in New Orleans |
Clinical Investigators Urged to Tell Study Participants of Financial Conflicts
August 27, 2009, 10:21 am
Confirm Your Email Address
You must confirm the email address associated with your account to use this Chronicle feature.
If you have already confirmed your account, try refreshing your browser.
E-mail a Friend

